News coverage about Imperva (NASDAQ:IMPV) has been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Imperva earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned news coverage about the software maker an impact score of 45.8940565414267 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Here are some of the media stories that may have effected Accern Sentiment’s rankings:
- Imperva, Inc. (IMPV)- Institutional Investors Salvations – Wallstreet Investorplace (wallstreetinvestorplace.com)
- Imperva, Inc. (NasdaqGS:IMPV) Valued at 1409925 – Clawson News (clawsonnews.com)
- Imperva Appoints David Gee as Chief Marketing Officer (finance.yahoo.com)
- Imperva to Report Fourth Quarter and Full Year 2017 Financial Results (finance.yahoo.com)
Imperva (NASDAQ:IMPV) opened at $44.30 on Wednesday. Imperva has a one year low of $37.17 and a one year high of $52.40. The company has a market capitalization of $1,510.00, a P/E ratio of 164.07 and a beta of 1.78.
A number of analysts have commented on the company. Zacks Investment Research cut Imperva from a “buy” rating to a “hold” rating in a research report on Wednesday, January 10th. BidaskClub upgraded Imperva from a “sell” rating to a “hold” rating in a research report on Friday, January 5th. JPMorgan Chase & Co. cut Imperva from a “neutral” rating to an “underweight” rating and set a $45.00 price target for the company. in a research report on Tuesday, December 12th. Morgan Stanley restated an “underweight” rating and issued a $39.00 price target on shares of Imperva in a research report on Thursday, November 9th. Finally, Oppenheimer restated a “buy” rating and issued a $55.00 price target on shares of Imperva in a research report on Thursday, November 9th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and nine have assigned a buy rating to the stock. Imperva has a consensus rating of “Hold” and an average target price of $51.86.
COPYRIGHT VIOLATION NOTICE: “Imperva (NASDAQ:IMPV) Receiving Somewhat Favorable Media Coverage, Analysis Shows” was originally published by BBNS and is owned by of BBNS. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at https://baseballnewssource.com/markets/imperva-impv-earning-somewhat-positive-news-coverage-study-finds/1822255.html.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.